These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18166372)

  • 1. Severe hepatitis C recurrence: is it a negative predictive factor for sustained response to treatment?
    Oton E; Barcena R
    Gastroenterology; 2008 Jan; 134(1):367; author reply 367-8. PubMed ID: 18166372
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral treatment of recurrent hepatitis C after liver transplantation: the need for a multifaceted approach.
    Samuel D
    Hepatology; 2005 Mar; 41(3):436-8. PubMed ID: 15723322
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C therapy before and after liver transplantation.
    Terrault NA
    Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success.
    Samuel D; Roche B
    J Hepatol; 2007 Jun; 46(6):988-91. PubMed ID: 17445936
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation in viral hepatitis: prevention of recurrence.
    Roche B; Samuel D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1153-69. PubMed ID: 19187873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of liver transplant recipients with recurrent hepatitis C.
    McCashland TM
    Curr Opin Organ Transplant; 2009 Jun; 14(3):221-4. PubMed ID: 19444107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroids in recurrent hepatitis C following liver transplantation: pitfall or panacea?
    Brown RS
    J Hepatol; 2007 Dec; 47(6):741-3. PubMed ID: 17933416
    [No Abstract]   [Full Text] [Related]  

  • 10. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in liver transplantation for hepatitis C.
    Mukherjee S; Sorrell MF
    Gastroenterology; 2008 May; 134(6):1777-88. PubMed ID: 18471554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C.
    Colletta C; Smirne C; Marini C; Pirisi M
    J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of posttransplantation hepatitis C virus disease--is it the host, the virus, or how we modify the host and/or the virus?
    Berenguer M
    Liver Transpl; 2002 Oct; 8(10):889-91. PubMed ID: 12360429
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact.
    Walter T; Scoazec JY; Guillaud O; Hervieu V; Chevallier P; Boillot O; Dumortier J
    Liver Transpl; 2009 Jan; 15(1):54-63. PubMed ID: 19109834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
    Kuo A; Terrault NA
    J Hepatol; 2007 Mar; 46(3):359-61. PubMed ID: 17223220
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy of recurrent hepatitis C in liver transplantation.
    Fernández I; Loinaz C
    Rev Esp Enferm Dig; 2004 Mar; 96(3):201-14. PubMed ID: 15053735
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of posttransplantation viral hepatitis C.
    Shiffman ML
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S79-86. PubMed ID: 9742498
    [No Abstract]   [Full Text] [Related]  

  • 20. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.